Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers-Reference-Cited by-同舟云学术

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

Published:2012-06 Issue:6 Volume:56 Page:1363-1370
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Shen Jiayun,Chan Henry Lik-Yuen,Wong Grace Lai-Hung,Choi Paul Cheung-Lung,Chan Anthony Wing-Hung,Chan Hoi-Yun,Chim Angel Mei-Ling,Yeung David Ka-Wai,Chan Francis Ka-Leung,Woo Jean,Yu Jun,Chu Winnie Chiu-Wing,Wong Vincent Wai-Sun

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. Nonalcoholic fatty liver disease: from steatosis to cirrhosis;Farrell;Hepatology,2006

2. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese;Wong;Aliment Pharmacol Ther,2004

3. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease;Wong;Clin Gastroenterol Hepatol,2006

4. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20years;Feldstein;Gut,2009

5. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance;Newton;Gut,2008

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring non-invasive diagnostics for metabolic dysfunction-associated fatty liver disease;World Journal of Gastroenterology;2024-07-28

2. Artificial intelligence as a ploy to delve into the intricate relationship between genetics and mitochondria in MASLD patients;2024-06-04

3. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD;Current Obesity Reports;2024-05-29

4. Sequential ultrasound molecular imaging for noninvasive identification and assessment of non-alcoholic steatohepatitis in mouse models;Liver Research;2023-12

5. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease;Metabolites;2023-10-29